Researcher.Life Logo

Nuklearmedizin - NuclearMedicine : Impact Factor & More

eISSN: 2567-6407pISSN: 0029-5566

Key Metrics

CiteScore
1.5
SNIP
0.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Nuklearmedizin - NuclearMedicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher GEORG THIEME VERLAG KG
Language Multi-Language
Frequency Bi-monthly
General Details
LanguageMulti-Language
FrequencyBi-monthly
Publication Start Year1959
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nuklearmedizin - NuclearMedicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nuklearmedizin - NuclearMedicine

Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes.
  • 2 Feb 2026
  • Nuklearmedizin. Nuclear medicine
Title not available
  • 1 Feb 2026
  • Nuklearmedizin - NuclearMedicine
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.
  • 29 Jan 2026
  • Nuklearmedizin. Nuclear medicine
Nuclear cardiology - Current status of the clinical application.
  • 16 Jan 2026
  • Nuklearmedizin. Nuclear medicine
Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer.
  • 4 Dec 2025
  • Nuklearmedizin. Nuclear medicine
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors.
  • 1 Dec 2025
  • Nuklearmedizin. Nuclear medicine
Radioactive Gold Isotopes in the Era of Theranostics: Medical Potential of ¹⁹⁸Au and ¹⁹⁹Au Radioisotopes.
  • 2 Feb 2026
  • Nuklearmedizin. Nuclear medicine
Title not available
  • 1 Feb 2026
  • Nuklearmedizin - NuclearMedicine
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.
  • 29 Jan 2026
  • Nuklearmedizin. Nuclear medicine
Nuclear cardiology - Current status of the clinical application.
  • 16 Jan 2026
  • Nuklearmedizin. Nuclear medicine
Primary Tumor Localization is Associated with Progression-free Survival and Overall Survival after Selective-Internal-Radio-Therapy of Liver Metastases in Metastatic Colorectal Cancer.
  • 4 Dec 2025
  • Nuklearmedizin. Nuclear medicine
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors.
  • 1 Dec 2025
  • Nuklearmedizin. Nuclear medicine

FAQs on Nuklearmedizin - NuclearMedicine